LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data from the DELTA FORCE trial at the 33rd European Academy of Dermatology and Venereology (EADV) Congress in…
Gastroenterologist and obesity medicine specialist Dr. Christopher McGowan performed the 5,000th endobariatric weight loss procedure this week at True You Weight Loss, marking the practice as the first in the…
Debiopharm Honors Recipients of 2024 JCA-Mauvernay Award for Breakthrough Cancer Research Debiopharm, a Swiss-based biopharmaceutical company focused on advancing cancer and infectious disease treatments, has announced the winners of the…
Prolucent®, a top provider of healthcare workforce optimization solutions, is excited to announce two key new hires to boost market expansion and sales growth. Jason Phibbs has been appointed Vice…
Axion BioSystems and STEMCELL Technologies are excited to announce a strategic partnership that will see STEMCELL distributing Axion’s advanced Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems across North…
Oticon Medical is pleased to announce that its Sentio System has been honored with the Hearing Technology Innovator Award™ in the category of Auditory Implants: Bone Conduction at the fifth…
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is set to launch HMH 24/7, an AI-driven solution designed to enhance primary care by seamlessly integrating virtual and…
Tempus AI, Inc. (NASDAQ: TEM), a leader in using AI for precision medicine, has announced that four of its abstracts have been accepted for the European Society for Medical Oncology…
Rising Pharmaceuticals, Inc. has announced the commercial launch of Edetate calcium disodium injection. Despite a current shortage of this product in the U.S., Rising’s version remains available. Rising Pharmaceuticals, Inc.…
As people age or experience life events like childbirth, maintaining pelvic muscle strength can be challenging. While Kegel exercises are a well-known solution, they are often overlooked. Developed by Dr.…
Results from the DESTINY-Breast12 phase 3b/4 trial reveal that ENHERTU® (trastuzumab deruxtecan) demonstrated significant clinical activity in HER2-positive metastatic breast cancer patients with brain metastases who had received up to…
Spencer Health Solutions (SHS), a leader in intelligent medication management technology, has announced its achievement of ISO 27001:2022 certification. This esteemed accreditation highlights SHS’s dedication to safeguarding patient data and…